Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 45 Results

Title
Intervention Indication Therapeutic Area Year Actions
Nintedanib for Systemic Sclerosis Associated Interstitial Lung Disease Nintedanib (Vargatef; Ofev; nintedanib esilate) Interstitial lung disease (ILD) Dermatology , Respiratory System 2018 View  |  Download
Nintedanib for treating interstitial lung disease in children aged 6 to 17 years old Nintedanib (Vargatef; Ofev; nintedanib esilate) Interstitial lung disease (ILD) Dermatology , Respiratory System 2022 View  |  Download
Sotatercept for treating pulmonary arterial hypertension Sotatercep (ACE-011) Pulmonary arterial hypertension (PAH) Cardiovascular System , Respiratory System 2022 View  |  Download
Tezacaftor and ivacaftor for cystic fibrosis homozygous or heterozygous for F508del mutation in patients aged 12 years and older who discontinued treatment with Orkambi Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2019 View  |  Download
Tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis heterozygous for F508del mutation and one residual mutation in patients aged 6 to 11 years Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2019 View  |  Download
Tezacaftor/ivacaftor (fixed-dose combination) for cystic fibrosis homozygous for F508del mutation in patients aged 6 to 11 years Ivacaftor (Kalydeco; VX-770) , Symkevi (fixed dose combination: Tezacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2019 View  |  Download
Tezepelumab for severe, uncontrolled asthma Tezepelumab (AMG 157; MEDI9929) Asthma Respiratory System 2020 View  |  Download
Tocilizumab (RoActemra) for Adults with Systemic Sclerosis – Second Line Tocilizumab (Actemra; R1569; RoActemra) Systemic sclerosis Dermatology , Respiratory System 2017 View  |  Download
Tralokinumab for severe, uncontrolled asthma Tralokinumab (CAT-354; LP 0162) Asthma Respiratory System 2017 View  |  Download
Treprostinil diethanolamine for treating pulmonary arterial hypertension Treprostinil diethanolamine Paroxysmal nocturnal haemoglobinuria Cardiovascular System , Respiratory System 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications